Pearls & Oy-sters: Arterial Wall Enhancements and Rapid Clinical Progression in Noninflammatory Cerebral Amyloid

João Moura1,2, Vasco Abreu3, João Pedro Filipe3

  • 1Department of Neurology, Centro Hospitalar Universitário de Santo António, Porto, Portugal.

Neurology
|June 23, 2025
PubMed

Insights

Cerebral amyloid angiopathy (CAA) can cause severe cognitive decline and intracerebral hemorrhage. This case shows Aβ accumulation alone can mimic inflammation on MRI, highlighting diagnostic challenges in CAA progression.

Area of Science:

  • Neurology
  • Neuroradiology
  • Pathology

Background:

  • Cerebral amyloid angiopathy (CAA) is a leading cause of lobar intracerebral hemorrhage (ICH) and cognitive impairment.
  • Revised diagnostic criteria for CAA are now available.
  • CAA-related inflammation can lead to a more severe clinical course.

Purpose of the Study:

  • To present a case of severe cerebral amyloid angiopathy (CAA) with atypical progression.
  • To investigate the diagnostic utility of neuroimaging in differentiating CAA from inflammatory conditions.
  • To explore the association between Aβ accumulation and arterial wall enhancement in CAA.

Main Methods:

  • Case report of a 61-year-old man with cerebral amyloid angiopathy (CAA).
  • Clinical evaluation including neurological exams and cerebrospinal fluid (CSF) analysis for β-amyloid (Aβ) levels.
  • Serial brain MRI, including high-resolution vessel wall MRI.

Main Results:

  • The patient presented with ICH and cognitive impairment consistent with probable CAA.
  • Atypical rapid cognitive deterioration occurred later in the disease course.
  • High-resolution vessel wall MRI showed arterial wall enhancement, mimicking vasculitis, but pathology confirmed severe CAA without inflammation.

Conclusions:

  • Aβ accumulation in CAA, even without inflammation, can cause arterial wall enhancement on MRI.
  • This imaging finding can mimic inflammatory processes like vasculitis or CAA-related inflammation.
  • Periods of steep progression in CAA are possible and require careful diagnostic consideration.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
684
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
27
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
36
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
42
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
39